https://www.selleckchem.com/pr....oducts/aticaprant.ht
To compare safety and efficacy of combined therapy with conventional transarterial chemoembolization (cTACE)+microwave ablation (MWA) versus only TACE or MWA for treatment of hepatocellular carcinoma (HCC) 3-5 cm. This randomized controlled trial (NCT0472147 screened 278 patients with HCC 3-5 cm. Patients were randomized into three groups 90 underwent TACE (Group 1); 95 underwent MWA (Group 2); and 93 underwent combined therapy (Group 3). Patients were followed-up with contrast-enhanced CT or MRI. Images were evalua
Curtir
Comentario
Compartilhar
